Neurology Advisor (10/18) reports researchers found in a medical literature review that “for most patients, treatment with clozapine can produce a slight reduction in the antipsychotic-induced movement disorder tardive dyskinesia and can greatly reduce the disorder’s severity in patients with moderate to severe cases.” The findings were published online Sept. 18 in the Journal of Clinical Psychiatry.
Related Links:
— “Clozapine Monotherapy Improves Antipsychotic-Induced Tardive Dyskinesia, Neurology Advisor, October 18, 2018.